Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.

Leukemia research - 1 Apr 2023

Suknuntha Kran, Geyer Julia T, Patel Keyur Pravinchandra, Weinberg Olga K, Rogers Heesun J, Lake Jonathan I, Lauridsen Luke, Patel Jay L, Kluk Michael J, Arber Daniel A, Hsi Eric D, Bagg Adam, Bueso-Ramos Carlos, Orazi Attilio

Abstract excerpt

The presence of JAK2 exon 12 mutation was included by the 2016 World Health Organization (WHO) Classification as one of the major criteria for diagnosing polycythemia vera (PV). Few studies have evaluated the clinical presentation and bone marrow morphology of these patients and it is unclear if these patients fulfill the newly published criteria of 5th edition WHO or The International Consensus Classification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Exons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Mutation

Share to Myeloproliferative Disorders

Share to Polycythemia

Share to Polycythemia Vera

Source

Identifiers

PMID: 36774789
DOI: 10.1016/j.leukres.2023.107033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation.PMID 36774789Read ↗

Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.Semantic proximity Read ↗

The spectrum of JAK2-positive myeloproliferative neoplasmsSemantic proximity Read ↗

The spectrum of JAK2-positive myeloproliferative neoplasms.Semantic proximity Read ↗

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.Semantic proximity Read ↗

Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.Semantic proximity Read ↗

Guidelines for the management of myeloproliferative neoplasms.Semantic proximity Read ↗

Validation of the revised 2008 WHO diagnostic criteria in 75 suspected cases of myeloproliferative neoplasm.Semantic proximity Read ↗

The JAK2 exon 12 mutations: a comprehensive review.Semantic proximity Read ↗

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Polycythemia vera: from new, modified diagnostic criteria to new therapeutic approaches.Semantic proximity Read ↗

Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F EraSemantic proximity Read ↗

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.